calendar
23,587 catalysts · 5,000 device 510k · 4,728 grant · 3,915 approval · 3,153 8k filing · 2,000 device pma · 2,000 device recall
23,587 catalysts · 5,000 device 510k · 4,728 grant · 3,915 approval · 3,153 8k filing · 2,000 device pma · 2,000 device recall
Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional
Product code: HQF. Advisory committee: Ophthalmic. Type: Traditional
Product code: KNT. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: FLL. Advisory committee: General Hospital. Type: Traditional
Product code: QIH. Advisory committee: Radiology. Type: Traditional
Product code: JWH. Advisory committee: Orthopedic. Type: Special
Product code: GEH. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: OYK. Advisory committee: Orthopedic. Type: Special
Product code: QNS. Advisory committee: General Hospital. Type: Special
Product code: SDD. Advisory committee: General, Plastic Surgery. Type: Direct
Product code: LPL. Advisory committee: Ophthalmic. Type: Traditional
Product code: OHT. Advisory committee: General, Plastic Surgery. Type: Special
Product code: OYK. Advisory committee: Orthopedic. Type: Special
Product code: LOX. Advisory committee: Cardiovascular. Type: Special
Product code: QOF. Advisory committee: Microbiology. Type: Special
Product code: MUH. Advisory committee: Dental. Type: Traditional
Product code: NQX. Advisory committee: Microbiology. Type: Special
Product code: LZA. Advisory committee: General Hospital. Type: Traditional
Sponsor: TWI PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Product code: OVD. Advisory committee: Orthopedic. Type: Traditional
Product code: GDW. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: QRK. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: NQW. Advisory committee: Orthopedic. Type: Special
Product code: NKB. Advisory committee: Orthopedic. Type: Traditional
Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: QKQ. Advisory committee: Pathology. Type: Traditional
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS. Form: TABLET. Route: ORAL
Product code: NRY. Advisory committee: Cardiovascular. Type: Special
Product code: EOQ. Advisory committee: Ear, Nose, Throat. Type: Traditional
Product code: CBP. Advisory committee: Anesthesiology. Type: Traditional
Product code: KNW. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: GXH. Advisory committee: Neurology. Type: Special
Product code: MBI. Advisory committee: Orthopedic. Type: Special
Product code: PLO. Advisory committee: Microbiology. Type: Traditional
Product code: HWC. Advisory committee: Orthopedic. Type: Traditional
Product code: MBH. Advisory committee: Orthopedic. Type: Special
Product code: JAQ. Advisory committee: Radiology. Type: Traditional
Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional
Product code: NWA. Advisory committee: General, Plastic Surgery. Type: Special
Product code: OVD. Advisory committee: Orthopedic. Type: Traditional
Sponsor: TG THERAPEUTICS, INC. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ABLYNX NV. Form: INJECTABLE. Route: INJECTION
Sponsor: OSMOTICA PHARM US. Form: TABLET, EXTENDED RELEASE. Route: ORAL
NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-027-58 — Reason: cGMP violations — Status: Terminated
Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-010-58 — Reason: cGMP violations — Status: Terminated
EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-060-58 — Reason: cGMP violations — Status: Terminated
Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-028-59 — Reason: cGMP violations — Status: Terminated
AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg, — Reason: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen. — Status: Ongoing